1-(5-Bromo-2-(trifluoromethoxy)phenyl)-2,5-dimethyl-1H-pyrrole, 98%, 1g

2-Cyanoquinuclidine, 97%, 250mg

3-Pyridin-3-ylpropanoic acid, 97.0%, 100g

4-N-Boc-amino-piperidine-4-carboxylic acid methyl ester oxalate, 97.0%, 1g

N-1,3-benzothiazol-2-yl-N-methylglycine, 95.0%, 2.5g

5-bromo-2-(dimethylamino)-4,6-dimethylpyridine-3-carbonitrile, 95.0%, 500mg

2-Chloro-3-(1-pyrrolidinylcarbonyl)pyridine, 97.0%, 5g

1-[(TERT-BUTYL)OXYCARBONYL]-3-PYRIDIN-4-YLMETHYLPIPERIDINE-3-CARBOXYLIC ACID, 95.0%, 1g

Oxyde d'hydroxyde de fer(III), minimum 85 % Fe2O3, technique, 250 g, emballage plastique.

Methyl imidazo[1,2-a]pyridine-7-carboxylate, 95.0%, 50g

5-Bromo-2-methylaniline, 97.0%, 25g

2-CHLORO-4-FLUOROBENZO[D]OXAZOLE, 95.0%, 100mg

1H,1H,2H,2H-Tridecafluoro-n-octyl Iodide>97.0%(GC)25g